Ceribell president and CEO Chao Xingjuan sells $145,753 in stock
What it means
- What to watch: There is a hard number in this story ($145,753) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $CBLL +4.86% in the latest session.
- Timing: It landed after the closing bell, so the session change beside it was locked in before the story existed. The next session is the first that could react.
Where the stock stands
$CBLL last traded at $28.27, +4.86% on the session. That puts it 2.1% shy of its 52-week high of $28.89 and 161% clear of its low of $10.85 — within a tenth of its 52-week high. Over the year it has ranged 166% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $CBLL page.
How much coverage it is getting
Nothing else on $CBLL in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
What to watch next
The $CBLL page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $CBLL sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $CBLL. It carried $145,753, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 25, 2026. $CBLL has moved +20.55% ($23.45 to $28.27). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.